Matthew A. Sparks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Matthew A. Sparks has a total of 794 co-authors. Here are the top co-authors by number of shared publications:
Susan B. Gurley
Division of Nephrology and Hypertension, Oregon Health & Science University, Portland, Oregon
9 shared publications- Thomas M. Coffman
Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina, USA
9 shared publications Thomas M. Coffman
Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina
8 shared publications- Joel Michels Topf
Oakland University, USA
6 shared publications Johannes Stegbauer
§Cardiovascular and Metabolic Disorders Research Program, Duke-National University of Singapore, Graduate Medical School, Singapore
6 shared publications- Samira S. Farouk
Barbara T. Murphy Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York NY, USA
6 shared publications
Latest Publications
- 17 March 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (11) , 2075-2077
Sports Nephrology
An abstract is unavailable. This article is available as a PDF only.
- 17 March 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (11) , 2075-2077
Sports Nephrology
An abstract is unavailable. This article is available as a PDF only.
- 9 February 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
American Board of Internal Medicine Nephrology
An abstract is unavailable. This article is available as a PDF only.
- 9 February 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
American Board of Internal Medicine Nephrology
An abstract is unavailable. This article is available as a PDF only.
- 26 December 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (1)
Belimumab versus calcineurin inhibitors for cancer risk in lupus nephritis
- 26 December 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (1)
Belimumab versus calcineurin inhibitors for cancer risk in lupus nephritis
- 4 November 2025
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 60 (5) , 479-485
Impact of Treatment Modalities on Intensive Care Unit Length of Stay for Patients Admitted With Severe Hyponatremia
Background: The diversity in presentation and cause of hyponatremia leads to a wide array of treatment modalities which are selected based on severity, chronicity, volume status, and putative cause. Due to the variability in treatment selection, it is pertinent to identify the clinical impact of the various treatment modalities and rescue therapies to inform future care. Objective: To evaluate the association between treatment modality and length of stay for patients with severe hyponatremia Methods: This single-center, retrospective study included patients 18 years of age or older with glucose-corrected serum sodium levels of <125 mEq/L upon admission to the intensive care unit (ICU). The primary endpoint was ICU length of stay, and its association with treatment modality was assessed using multivariable Poisson regression with the following explanatory variables: 3% sodium chloride, 1.8% sodium chloride or isotonic fluids, diuretics, proactive therapy, rescue therapy, nephrology consultation, baseline volume status, and pretreatment sodium level. Results: Eighty-two patients were included with a median age of 65 years old (Q1, Q3: 57, 72). The median glucose-corrected serum sodium was 116.3 mEq/L (Q1, Q3: 112.9, 120.5) and the median ICU length of stay was 3 days (Q1, Q3: 2, 4). Multivariable analysis, adjusting for baseline serum sodium levels, revealed the use of proactive and early reactive therapy (incidence rate ratio [IRR] 1.38, 95% confidence interval [CI] 1.11-1.71) and nephrology consultation (IRR 1.22, 95% CI 1.01-1.46) were associated with increased length of ICU stay. Conclusions and Relevance: Nephrology consultation and the use of proactive therapies were associated with increased ICU length of stay. Accurate identification of patients at high risk for osmotic demyelination syndrome that may benefit from proactive therapies is imperative, as use of proactive therapies in low-risk patients may prolong length of stay.
- 4 November 2025
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 60 (5) , 479-485
Impact of Treatment Modalities on Intensive Care Unit Length of Stay for Patients Admitted With Severe Hyponatremia
Background: The diversity in presentation and cause of hyponatremia leads to a wide array of treatment modalities which are selected based on severity, chronicity, volume status, and putative cause. Due to the variability in treatment selection, it is pertinent to identify the clinical impact of the various treatment modalities and rescue therapies to inform future care. Objective: To evaluate the association between treatment modality and length of stay for patients with severe hyponatremia Methods: This single-center, retrospective study included patients 18 years of age or older with glucose-corrected serum sodium levels of <125 mEq/L upon admission to the intensive care unit (ICU). The primary endpoint was ICU length of stay, and its association with treatment modality was assessed using multivariable Poisson regression with the following explanatory variables: 3% sodium chloride, 1.8% sodium chloride or isotonic fluids, diuretics, proactive therapy, rescue therapy, nephrology consultation, baseline volume status, and pretreatment sodium level. Results: Eighty-two patients were included with a median age of 65 years old (Q1, Q3: 57, 72). The median glucose-corrected serum sodium was 116.3 mEq/L (Q1, Q3: 112.9, 120.5) and the median ICU length of stay was 3 days (Q1, Q3: 2, 4). Multivariable analysis, adjusting for baseline serum sodium levels, revealed the use of proactive and early reactive therapy (incidence rate ratio [IRR] 1.38, 95% confidence interval [CI] 1.11-1.71) and nephrology consultation (IRR 1.22, 95% CI 1.01-1.46) were associated with increased length of ICU stay. Conclusions and Relevance: Nephrology consultation and the use of proactive therapies were associated with increased ICU length of stay. Accurate identification of patients at high risk for osmotic demyelination syndrome that may benefit from proactive therapies is imperative, as use of proactive therapies in low-risk patients may prolong length of stay.
- Open Access
- 25 September 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (9) , 1430-1432
Use of the Desmopressin Clamp in Hyponatremia
- 25 September 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (9) , 1430-1432
Open AccessUse of the Desmopressin Clamp in Hyponatremia
- 16 September 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (11) , 1639-1644
Transforming Dialysis Access Together Dialysis Access Training
- 16 September 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (11) , 1639-1644
Transforming Dialysis Access Together Dialysis Access Training
- Open Access
- 28 August 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (8) , 1422-1423
Asymptomatic Patient with ESKD Presenting with a Purple Peritoneal Dialysis Catheter
- 28 August 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (8) , 1422-1423
Open AccessAsymptomatic Patient with ESKD Presenting with a Purple Peritoneal Dialysis Catheter
- 18 August 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (11) , 2241-2243
Trends in Steroidal Mineralocorticoid Receptor Antagonist Prescriptions by Nephrologists after Approval of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone for CKD
- 18 August 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (11) , 2241-2243
Trends in Steroidal Mineralocorticoid Receptor Antagonist Prescriptions by Nephrologists after Approval of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone for CKD
- 19 February 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (4) , 539-546
Current State and Future Direction of Vascular Access Training in the United States
Key Points: Hands-on training is crucial for vascular access training. A multidisciplinary approach to vascular access training is paramount. Creation of a multifaceted vascular access curriculum is needed in all training programs. Background: This study seeks to provide insights into the current state of vascular access education in adult nephrology fellowship programs in the United States and to identify areas for improvement. Methods: A total of 63 adult nephrology programs and 71 second-year adult nephrology fellows were randomly selected for participation in a roundtable. Virtual roundtable discussions preceded by a survey were conducted to gather information on the delivery of vascular access education. Descriptive statistics were used for analysis. Results: Among the respondents invited to the roundtable discussions, 42 individuals (30 faculty and 12 fellows) completed the survey, while 21 individuals (13 faculty and eight fellows) also participated in the roundtable discussion. Of these respondents, most (67%) didactic lectures on vascular access in fellowship programs were delivered by general nephrologists, with 57% provided by interventional nephrologists, 36% by surgeons, and 17% by interventional radiologists (respondents were able to select multiple disciplines). The respondents reported limited exposure to proceduralists, including interventional nephrologists and vascular access surgeons during fellowship training. Faculty and fellows were less comfortable with physical examination skills related to vascular access, particularly in using point-of-care ultrasound and interpreting vascular imaging as compared with naming and identification of vascular access. Both groups emphasized the importance of hands-on modalities in vascular access education. Conclusion: Roundtable discussions highlighted the need for enhanced hands-on training, multidisciplinary collaboration, and standardized curricula in vascular access education. Recommendations were formulated in alignment with the three levels of competency outlined by the American Society of Nephrology Task Force on the Future of Nephrology, aiming to address gaps and improve the quality of vascular access education in nephrology fellowship programs. This study underscores the importance and need for a comprehensive vascular access education in nephrology fellowship training. By implementing the identified recommendations, programs can better prepare fellows to manage vascular access-related challenges in clinical practice.
- 19 February 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (4) , 539-546
Current State and Future Direction of Vascular Access Training in the United States
Key Points: Hands-on training is crucial for vascular access training. A multidisciplinary approach to vascular access training is paramount. Creation of a multifaceted vascular access curriculum is needed in all training programs. Background: This study seeks to provide insights into the current state of vascular access education in adult nephrology fellowship programs in the United States and to identify areas for improvement. Methods: A total of 63 adult nephrology programs and 71 second-year adult nephrology fellows were randomly selected for participation in a roundtable. Virtual roundtable discussions preceded by a survey were conducted to gather information on the delivery of vascular access education. Descriptive statistics were used for analysis. Results: Among the respondents invited to the roundtable discussions, 42 individuals (30 faculty and 12 fellows) completed the survey, while 21 individuals (13 faculty and eight fellows) also participated in the roundtable discussion. Of these respondents, most (67%) didactic lectures on vascular access in fellowship programs were delivered by general nephrologists, with 57% provided by interventional nephrologists, 36% by surgeons, and 17% by interventional radiologists (respondents were able to select multiple disciplines). The respondents reported limited exposure to proceduralists, including interventional nephrologists and vascular access surgeons during fellowship training. Faculty and fellows were less comfortable with physical examination skills related to vascular access, particularly in using point-of-care ultrasound and interpreting vascular imaging as compared with naming and identification of vascular access. Both groups emphasized the importance of hands-on modalities in vascular access education. Conclusion: Roundtable discussions highlighted the need for enhanced hands-on training, multidisciplinary collaboration, and standardized curricula in vascular access education. Recommendations were formulated in alignment with the three levels of competency outlined by the American Society of Nephrology Task Force on the Future of Nephrology, aiming to address gaps and improve the quality of vascular access education in nephrology fellowship programs. This study underscores the importance and need for a comprehensive vascular access education in nephrology fellowship training. By implementing the identified recommendations, programs can better prepare fellows to manage vascular access-related challenges in clinical practice.
- Top Cited PapersOpen Access
- 7 February 2025
- Published by Elsevier in Kidney International
- Vol. 107 (5) , 852-868
Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease
- 7 February 2025
- Published by Elsevier in Kidney International
- Vol. 107 (5) , 852-868
Top Cited PapersOpen AccessFibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease